P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

Detalles Bibliográficos
Autores principales: Callaghan, M, Ataga, K, De Franceschi, L, Minniti, C, Balachandran, N, Imbs, D, Perretti, T, Ramos, J, Sostelly, A, Bartolucci, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812079/
http://dx.doi.org/10.1097/01.HS9.0000821572.78026.e4
_version_ 1784644571339161600
author Callaghan, M
Ataga, K
De Franceschi, L
Minniti, C
Balachandran, N
Imbs, D
Perretti, T
Ramos, J
Sostelly, A
Bartolucci, P
author_facet Callaghan, M
Ataga, K
De Franceschi, L
Minniti, C
Balachandran, N
Imbs, D
Perretti, T
Ramos, J
Sostelly, A
Bartolucci, P
author_sort Callaghan, M
collection PubMed
description
format Online
Article
Text
id pubmed-8812079
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88120792022-02-18 P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) Callaghan, M Ataga, K De Franceschi, L Minniti, C Balachandran, N Imbs, D Perretti, T Ramos, J Sostelly, A Bartolucci, P Hemasphere Poster Presentations Lippincott Williams & Wilkins 2022-01-31 /pmc/articles/PMC8812079/ http://dx.doi.org/10.1097/01.HS9.0000821572.78026.e4 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Poster Presentations
Callaghan, M
Ataga, K
De Franceschi, L
Minniti, C
Balachandran, N
Imbs, D
Perretti, T
Ramos, J
Sostelly, A
Bartolucci, P
P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_fullStr P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full_unstemmed P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_short P120: TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_sort p120: trial in progress: the randomized, double-blind, placebo-controlled phase 2a crosswalk-c trial evaluating the efficacy of crovalimab as adjunct treatment in the prevention of vaso-occlusive episodes (voes) in patients (pts) with sickle cell disease (scd)
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812079/
http://dx.doi.org/10.1097/01.HS9.0000821572.78026.e4
work_keys_str_mv AT callaghanm p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT atagak p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT defranceschil p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT minnitic p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT balachandrann p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT imbsd p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT perrettit p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT ramosj p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT sostellya p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT bartoluccip p120trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd

Ejemplares similares